Amoy Diagnostics Co., Ltd. (300685.SZ)
CNY 21.0
(-0.43%)
CNY 21.0
(-0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.03 Billion | 842.18 Million | 917.03 Million | 728.39 Million | 578.35 Million | 439.03 Million |
| Cost of Revenue | 167.29 Million | 147.81 Million | 143.27 Million | 94.94 Million | 55.7 Million | 39.35 Million |
| Gross Profit | 871.54 Million | 694.36 Million | 773.75 Million | 633.44 Million | 522.64 Million | 399.67 Million |
| Operating Expenses | 574.96 Million | 524.25 Million | 508.89 Million | 415.03 Million | 365.74 Million | 263.24 Million |
| Selling, General and Administrative Expenses | 361.48 Million | 346.31 Million | 357.69 Million | 321.47 Million | 268.15 Million | 182.79 Million |
| Research and Development Expenses | 203.21 Million | 174.53 Million | 156.11 Million | 115.1 Million | 93.75 Million | 78.33 Million |
| Other Expenses | - | -1.57 Million | -1.25 Million | -1.43 Million | -1.1 Million | -1.54 Million |
| Cost and Expenses | 742.25 Million | 672.06 Million | 652.17 Million | 509.98 Million | 421.44 Million | 302.6 Million |
| Operating Income | 301.24 Million | 287.66 Million | 253.23 Million | 202.14 Million | 162.45 Million | 143.92 Million |
| Interest Expense | 1.56 Million | 993.05 Thousand | 375.16 Thousand | 859.07 Thousand | 50.25 Thousand | 605.77 Thousand |
| Income Tax Expense | 33.37 Million | 21.79 Million | 12.95 Million | 20.38 Million | 25.87 Million | 15.63 Million |
| Earnings before Tax | 294.85 Million | 286.08 Million | 251.97 Million | 200.7 Million | 161.34 Million | 142.37 Million |
| Net Income | 261.48 Million | 263.74 Million | 239.57 Million | 180.32 Million | 135.47 Million | 126.73 Million |
| Earnings Per Share Basic | 0.66 | 0.67 | 0.60 | 0.46 | 0.52 | 0.33 |
| Earnings Per Share Diluted | 0.66 | 0.67 | 0.60 | 0.45 | 0.52 | 0.33 |
| Weighted Average Shares Outstanding | 396.18 Million | 393.64 Million | 395.62 Million | 395.83 Million | 259.41 Million | 388.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 396.18 Million | 393.64 Million | 399.28 Million | 400.72 Million | 259.41 Million | 388.85 Million |
| Gross Margin | 0.84 | 0.82 | 0.84 | 0.87 | 0.90 | 0.91 |
| EBIT Margin | 0.34 | 0.29 | 0.33 | 0.33 | 0.33 | 0.38 |
| Profit Margin | 0.25 | 0.31 | 0.26 | 0.25 | 0.23 | 0.29 |
| EBITDA | 352.59 Million | 350.61 Million | 291.26 Million | 228.89 Million | 193.34 Million | 162.69 Million |
| Earnings Before Tax Margin | 0.29 | 0.34 | 0.28 | 0.28 | 0.28 | 0.33 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 304.95 Million | 307.96 Million | 232.49 Million | 334.2 Million | 1.03 Billion | 248.88 Million |
| Cost of Revenue | 48.81 Million | 56.28 Million | 36.25 Million | 63.62 Million | 215.25 Million | 40.87 Million |
| Gross Profit | 256.13 Million | 251.67 Million | 196.23 Million | 270.57 Million | 823.57 Million | 208 Million |
| Operating Expenses | 162.7 Million | 178.89 Million | 133.22 Million | 171.28 Million | 555.12 Million | 152.63 Million |
| Selling, General and Administrative Expenses | 210.68 Million | 119.42 Million | 84.86 Million | 111.93 Million | - | 124.56 Million |
| Research and Development Expenses | 58.14 Million | 51.5 Million | 48.36 Million | 45.68 Million | - | 58.88 Million |
| Other Expenses | -106.12 Million | -7.96 Million | 5010.00 | -13.66 Million | -6.38 Million | -1.68 Million |
| Cost and Expenses | 211.52 Million | 235.18 Million | 169.47 Million | 234.91 Million | 770.38 Million | 193.51 Million |
| Operating Income | 93.03 Million | 72.78 Million | 63.01 Million | 99.29 Million | 268.45 Million | 51.64 Million |
| Interest Expense | 397.57 Thousand | 201.66 Thousand | 306.92 Thousand | 348.28 Thousand | 1.19 Million | 197.1 Thousand |
| Income Tax Expense | 9.26 Million | 5.2 Million | 9.36 Million | 13.54 Million | 33.37 Million | 2.98 Million |
| Earnings before Tax | 92.68 Million | 85.21 Million | 74.77 Million | 106.08 Million | 307.66 Million | 49.95 Million |
| Net Income | 83.41 Million | 79.65 Million | 64.19 Million | 87.75 Million | 261.48 Million | 46.97 Million |
| Earnings Per Share Basic | 0.21 | 0.20 | 0.16 | 0.22 | - | 0.12 |
| Earnings Per Share Diluted | 0.21 | 0.20 | 0.16 | 0.22 | - | 0.12 |
| Weighted Average Shares Outstanding | 392.12 Million | 392.12 Million | 394.21 Million | 394.21 Million | 398.26 Million | 394.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 392.12 Million | 392.12 Million | 394.21 Million | 406.54 Million | 398.26 Million | 400.39 Million |
| Gross Margin | 0.84 | 0.82 | 0.84 | 0.81 | 0.79 | 0.84 |
| EBIT Margin | 0.31 | 0.29 | 0.30 | 0.34 | - | 0.21 |
| Profit Margin | 0.27 | 0.26 | 0.28 | 0.26 | 0.25 | 0.19 |
| EBITDA | 93.08 Million | 87.85 Million | 70.42 Million | 114.51 Million | - | 51.53 Million |
| Earnings Before Tax Margin | 0.31 | 0.24 | 0.27 | 0.30 | 0.26 | 0.21 |
XPPLF
LTA
NEOINFRA
BB
SAREGAMA
CVPBF